HA

Henning Afflerbach

CEO

Navigo Proteins GmbH

Leipzig, Saxony


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Navigo Proteins GmbH
Industry
research
Employees
47.0
Seniority
C suite

Technologies

Apache Google Tag Manager Hubspot WordPress.org Mobile Friendly Remote

Keywords

protein engineering affinity chromatography downstream processing proteindrugconjugates target specific delivery radiopharmaceuticals biotechnology research precision capturing precision targeting recombinant protein purification antibody purification custom affinity chromatography biopharmaceutical downstream processing affinity ligands protein drug conjugates radio conjugates cellular therapy multispecific ligands scaffold protein-based ligands protein x technology non-antibody purification affinity matrix development theranostics biotherapeutics phage display technology ribosome display technology target-specific affilin ligands effector modules high-throughput screening synthetic biology gmp-compliant manufacturing dynamic binding capacity (dbc) stable affinity probes selective binding characteristics protein purification methods next-generation biotherapeutics modular protein design clinical development biomolecular engineering immunogenicity reduction half-life extension targeted drug delivery process development timelines customization in affinity ligands amino acid library generation automated screening platforms high-quality libraries serum half-life adjustment novel biopharmaceutical products modular therapeutic constructs intellectual property protection collaborative development projects regulatory compliance in production biotechnology

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans